跳至主要内容
临床试验/NCT03198767
NCT03198767已完成2 期

A Randomized, Open Label, Two-part, Three-period, Cross Over Study to Investigate the Effects of Carbohydrate in Diet and to Evaluate Supplements on the Gastrointestinal Tolerability of LIK066 in Overweight or Obese Subjects

Novartis Pharmaceuticals1 个研究点 分布在 1 个国家目标入组 54 人开始时间: 2017年6月21日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
已完成
入组人数
54
试验地点
1
主要终点
Number of Episodes of Diarrhea (Part A and Part B)

研究概览

简要总结

The purpose of this study was to determine if LIK066 taken with a meal containing low carbohydrate is associated with less diarrhea compared to a high carbohydrate meal and to assess the potential effects of supplements such as psyllium or calcium carbonate on alleviating diarrhea associated with LIK066.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Basic Science
盲法
None

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • obese and overweight, BMI 25-50, HbA1C <10%

排除标准

  • Preexisting, clinically significant cardiovascular, liver, renal, or GI disease that is considered unstable; pregnancy, Type 1 diabetes; Other protocol-defined inclusion/exclusion criteria may apply

研究组 & 干预措施

Part A: LIK066 + P1: 50% CHO / P2: 25% CHO / P3: 0% CHO

Experimental

Period 1 (Day 1-3): Daily dose of 50 mg LIK066 + 50% carbohydrate (CHO) Period 2 (Day 9-11): Daily dose of 50 mg LIK066 + 25% carbohydrate Period 3 (Day 17-19): Daily dose of 50 mg LIK066 + 0% carbohydrate

干预措施: LIK066 (Drug)

Part A: LIK066 + P1: 50% CHO / P2: 25% CHO / P3: 0% CHO

Experimental

Period 1 (Day 1-3): Daily dose of 50 mg LIK066 + 50% carbohydrate (CHO) Period 2 (Day 9-11): Daily dose of 50 mg LIK066 + 25% carbohydrate Period 3 (Day 17-19): Daily dose of 50 mg LIK066 + 0% carbohydrate

干预措施: Carbohydrate 50% (Dietary Supplement)

Part A: LIK066 + P1: 50% CHO / P2: 25% CHO / P3: 0% CHO

Experimental

Period 1 (Day 1-3): Daily dose of 50 mg LIK066 + 50% carbohydrate (CHO) Period 2 (Day 9-11): Daily dose of 50 mg LIK066 + 25% carbohydrate Period 3 (Day 17-19): Daily dose of 50 mg LIK066 + 0% carbohydrate

干预措施: Carbohydrate 25% (Dietary Supplement)

Part A: LIK066 + P1: 50% CHO / P2: 25% CHO / P3: 0% CHO

Experimental

Period 1 (Day 1-3): Daily dose of 50 mg LIK066 + 50% carbohydrate (CHO) Period 2 (Day 9-11): Daily dose of 50 mg LIK066 + 25% carbohydrate Period 3 (Day 17-19): Daily dose of 50 mg LIK066 + 0% carbohydrate

干预措施: Carbohydrate 0% (Dietary Supplement)

Part A: LIK066 + P1: 25% CHO / P2: 0% CHO / P3: 50% CHO

Experimental

Period 1 (Day 1-3): Daily dose of 50 mg LIK066 + 25% carbohydrate (CHO) Period 2 (Day 9-11): Daily dose of 50 mg LIK066 + 0% carbohydrate Period 3 (Day 17-19): Daily dose of 50 mg LIK066 + 50% carbohydrate

干预措施: LIK066 (Drug)

Part A: LIK066 + P1: 25% CHO / P2: 0% CHO / P3: 50% CHO

Experimental

Period 1 (Day 1-3): Daily dose of 50 mg LIK066 + 25% carbohydrate (CHO) Period 2 (Day 9-11): Daily dose of 50 mg LIK066 + 0% carbohydrate Period 3 (Day 17-19): Daily dose of 50 mg LIK066 + 50% carbohydrate

干预措施: Carbohydrate 50% (Dietary Supplement)

Part A: LIK066 + P1: 25% CHO / P2: 0% CHO / P3: 50% CHO

Experimental

Period 1 (Day 1-3): Daily dose of 50 mg LIK066 + 25% carbohydrate (CHO) Period 2 (Day 9-11): Daily dose of 50 mg LIK066 + 0% carbohydrate Period 3 (Day 17-19): Daily dose of 50 mg LIK066 + 50% carbohydrate

干预措施: Carbohydrate 25% (Dietary Supplement)

Part A: LIK066 + P1: 25% CHO / P2: 0% CHO / P3: 50% CHO

Experimental

Period 1 (Day 1-3): Daily dose of 50 mg LIK066 + 25% carbohydrate (CHO) Period 2 (Day 9-11): Daily dose of 50 mg LIK066 + 0% carbohydrate Period 3 (Day 17-19): Daily dose of 50 mg LIK066 + 50% carbohydrate

干预措施: Carbohydrate 0% (Dietary Supplement)

Part A: LIK066 + P1: 0% CHO / P2: 50% CHO / P3: 25% CHO

Experimental

Period 1 (Day 1-3): Daily dose of 50 mg LIK066 + 0% carbohydrate (CHO) Period 2 (Day 9-11): Daily dose of 50 mg LIK066 + 50% carbohydrate Period 3 (Day 17-19): Daily dose of 50 mg LIK066 + 25% carbohydrate

干预措施: LIK066 (Drug)

Part A: LIK066 + P1: 0% CHO / P2: 50% CHO / P3: 25% CHO

Experimental

Period 1 (Day 1-3): Daily dose of 50 mg LIK066 + 0% carbohydrate (CHO) Period 2 (Day 9-11): Daily dose of 50 mg LIK066 + 50% carbohydrate Period 3 (Day 17-19): Daily dose of 50 mg LIK066 + 25% carbohydrate

干预措施: Carbohydrate 50% (Dietary Supplement)

Part A: LIK066 + P1: 0% CHO / P2: 50% CHO / P3: 25% CHO

Experimental

Period 1 (Day 1-3): Daily dose of 50 mg LIK066 + 0% carbohydrate (CHO) Period 2 (Day 9-11): Daily dose of 50 mg LIK066 + 50% carbohydrate Period 3 (Day 17-19): Daily dose of 50 mg LIK066 + 25% carbohydrate

干预措施: Carbohydrate 25% (Dietary Supplement)

Part A: LIK066 + P1: 0% CHO / P2: 50% CHO / P3: 25% CHO

Experimental

Period 1 (Day 1-3): Daily dose of 50 mg LIK066 + 0% carbohydrate (CHO) Period 2 (Day 9-11): Daily dose of 50 mg LIK066 + 50% carbohydrate Period 3 (Day 17-19): Daily dose of 50 mg LIK066 + 25% carbohydrate

干预措施: Carbohydrate 0% (Dietary Supplement)

Part A: LIK066 + P1: 8% CHO

Experimental

Period 1 (Day 1-3): Daily dose of 50 mg LIK066 + 8% carbohydrate (CHO) PROTOCOL DEVIATION: subjects received 8% CHO in error and were discontinued after Period 1.

干预措施: LIK066 (Drug)

Part A: LIK066 + P1: 8% CHO

Experimental

Period 1 (Day 1-3): Daily dose of 50 mg LIK066 + 8% carbohydrate (CHO) PROTOCOL DEVIATION: subjects received 8% CHO in error and were discontinued after Period 1.

干预措施: Carbohydrate 8% (Dietary Supplement)

Part B: LIK066 + 50% CHO + P1: NS / P2: PS / P3: CC

Experimental

Period 1 (Day 1-3): Daily dose of 50 mg LIK066+50% carbohydrate + no supplement (NS) Period 2 (Day 9-11): Daily dose of 50 mg LIK066+50% carbohydrate + 6 g psyllium (PS) Period 3 (Day 17-19): Daily dose of 50 mg LIK066+50% carbohydrate +1g calcium carbonate (CC)

干预措施: LIK066 (Drug)

Part B: LIK066 + 50% CHO + P1: NS / P2: PS / P3: CC

Experimental

Period 1 (Day 1-3): Daily dose of 50 mg LIK066+50% carbohydrate + no supplement (NS) Period 2 (Day 9-11): Daily dose of 50 mg LIK066+50% carbohydrate + 6 g psyllium (PS) Period 3 (Day 17-19): Daily dose of 50 mg LIK066+50% carbohydrate +1g calcium carbonate (CC)

干预措施: Carbohydrate 50% (Dietary Supplement)

Part B: LIK066 + 50% CHO + P1: NS / P2: PS / P3: CC

Experimental

Period 1 (Day 1-3): Daily dose of 50 mg LIK066+50% carbohydrate + no supplement (NS) Period 2 (Day 9-11): Daily dose of 50 mg LIK066+50% carbohydrate + 6 g psyllium (PS) Period 3 (Day 17-19): Daily dose of 50 mg LIK066+50% carbohydrate +1g calcium carbonate (CC)

干预措施: Psyllium (Dietary Supplement)

Part B: LIK066 + 50% CHO + P1: NS / P2: PS / P3: CC

Experimental

Period 1 (Day 1-3): Daily dose of 50 mg LIK066+50% carbohydrate + no supplement (NS) Period 2 (Day 9-11): Daily dose of 50 mg LIK066+50% carbohydrate + 6 g psyllium (PS) Period 3 (Day 17-19): Daily dose of 50 mg LIK066+50% carbohydrate +1g calcium carbonate (CC)

干预措施: Calcium carbonate (Dietary Supplement)

Part B: LIK066 + 50% CHO + P1: PS / P2: CC / P3: NS

Experimental

Period 1 (Day 1-3): Daily dose of 50 mg LIK066+50% carbohydrate + 6 g psyllium (PS) Period 2 (Day 9-11): Daily dose of 50 mg LIK066+50% carbohydrate +1g calcium carbonate (CC) Period 3 (Day 17-19): Daily dose of 50 mg LIK066+50% carbohydrate + no supplement (NS)

干预措施: LIK066 (Drug)

Part B: LIK066 + 50% CHO + P1: PS / P2: CC / P3: NS

Experimental

Period 1 (Day 1-3): Daily dose of 50 mg LIK066+50% carbohydrate + 6 g psyllium (PS) Period 2 (Day 9-11): Daily dose of 50 mg LIK066+50% carbohydrate +1g calcium carbonate (CC) Period 3 (Day 17-19): Daily dose of 50 mg LIK066+50% carbohydrate + no supplement (NS)

干预措施: Carbohydrate 50% (Dietary Supplement)

Part B: LIK066 + 50% CHO + P1: PS / P2: CC / P3: NS

Experimental

Period 1 (Day 1-3): Daily dose of 50 mg LIK066+50% carbohydrate + 6 g psyllium (PS) Period 2 (Day 9-11): Daily dose of 50 mg LIK066+50% carbohydrate +1g calcium carbonate (CC) Period 3 (Day 17-19): Daily dose of 50 mg LIK066+50% carbohydrate + no supplement (NS)

干预措施: Psyllium (Dietary Supplement)

Part B: LIK066 + 50% CHO + P1: PS / P2: CC / P3: NS

Experimental

Period 1 (Day 1-3): Daily dose of 50 mg LIK066+50% carbohydrate + 6 g psyllium (PS) Period 2 (Day 9-11): Daily dose of 50 mg LIK066+50% carbohydrate +1g calcium carbonate (CC) Period 3 (Day 17-19): Daily dose of 50 mg LIK066+50% carbohydrate + no supplement (NS)

干预措施: Calcium carbonate (Dietary Supplement)

Part B: LIK066 + 50% CHO + P1: CC / P2: NS / P3: PS

Experimental

Period 1 (Day 1-3): Daily dose of 50 mg LIK066+50% carbohydrate +1g calcium carbonate (CC) Period 2 (Day 9-11): Daily dose of 50 mg LIK066+50% carbohydrate + no supplement (NS) Period 3 (Day 17-19): Daily dose of 50 mg LIK066+50% carbohydrate + 6 g psyllium (PS)

干预措施: LIK066 (Drug)

Part B: LIK066 + 50% CHO + P1: CC / P2: NS / P3: PS

Experimental

Period 1 (Day 1-3): Daily dose of 50 mg LIK066+50% carbohydrate +1g calcium carbonate (CC) Period 2 (Day 9-11): Daily dose of 50 mg LIK066+50% carbohydrate + no supplement (NS) Period 3 (Day 17-19): Daily dose of 50 mg LIK066+50% carbohydrate + 6 g psyllium (PS)

干预措施: Carbohydrate 50% (Dietary Supplement)

Part B: LIK066 + 50% CHO + P1: CC / P2: NS / P3: PS

Experimental

Period 1 (Day 1-3): Daily dose of 50 mg LIK066+50% carbohydrate +1g calcium carbonate (CC) Period 2 (Day 9-11): Daily dose of 50 mg LIK066+50% carbohydrate + no supplement (NS) Period 3 (Day 17-19): Daily dose of 50 mg LIK066+50% carbohydrate + 6 g psyllium (PS)

干预措施: Psyllium (Dietary Supplement)

Part B: LIK066 + 50% CHO + P1: CC / P2: NS / P3: PS

Experimental

Period 1 (Day 1-3): Daily dose of 50 mg LIK066+50% carbohydrate +1g calcium carbonate (CC) Period 2 (Day 9-11): Daily dose of 50 mg LIK066+50% carbohydrate + no supplement (NS) Period 3 (Day 17-19): Daily dose of 50 mg LIK066+50% carbohydrate + 6 g psyllium (PS)

干预措施: Calcium carbonate (Dietary Supplement)

结局指标

主要结局

Number of Episodes of Diarrhea (Part A and Part B)

时间窗: 24 hours on Day 3 of each treatment period

Episodes of diarrhea is defined as the total number of stools with a Bristol Stool Chart (BSC) Score of 6 or 7 on day 3 of each treatment period. BSC is frequently used as a measure of consistency, and a score of 6 or 7 (pourable or watery stool) is considered abnormal.

次要结局

  • Average Stool pH (Part A and Part B)(24 hours on Day 3 of each treatment period)
  • Average Consistency With Bristol Stool Chart (Part A and Part B)(24 hours on Day 3 of each treatment period)
  • Three-day Total Number of Episodes of Diarrhea (Part A and Part B)(Day 1 to 3 of each treatment period)
  • Average Stool Weight (Part A and Part B)(24 hours on Day 3 of each treatment period)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Effects of Carbohydrate in Diet and Supplements on... | 临床试验